Arylsulfonylimidazolone derivatives as an antitumor agent
US5929103A · kind A · utility
12Cited by
9References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 1997 |
| Grant date | Jul 27, 1999 |
| Priority date | — |
| Expiry date | Aug 21, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a novel arylsulfonylimidazolone derivative represented by the following formula (I) which shows a superior antineoplastic activity in contrast to the known sulfonylurea antitumor agents as well as little side effect: ##STR1## and its pharmaceutically acceptable salt and stereoisomer, in which ----, R.sub.1, and R.sub.2 are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.